PALO ALTO, Calif., May 23, 2016 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) has announced The University of Texas MD Anderson Cancer Center signed an agreement to acquire six TrueBeam™ linear accelerators. Scheduled for delivery over the next 24 months, the six TrueBeam systems will be added to the 24 Varian linear accelerators already treating patients at the cancer center.
"We have been able to deliver critical cancer treatments to thousands of cancer patients as well as collaborate on strong translational research programs and clinical trial support through Varian's technology," said Steve Hahn, chair, Division of Radiation Oncology at MD Anderson Cancer Center. "The additional TrueBeam systems will enable us to make advanced cancer care accessible to even more patients."
Varian's TrueBeam system is an advanced medical linear accelerator capable of fast and precise image-guided radiotherapy and radiosurgery. The system is equipped with a high dose delivery rate that enables most treatments to be completed faster than was possible with earlier generations of radiotherapy technology. It incorporates numerous technical innovations that dynamically synchronize imaging, patient positioning, motion management, and dose delivery during a treatment procedure. TrueBeam has been designed to advance the treatment of lung, breast, intracranial, prostate, head and neck, and other types of cancer.
"Varian is proud of its years of working with MD Anderson," said Kolleen Kennedy, president of Varian's Oncology Systems business. "We have worked together to improve the quality and effectiveness of cancer care for patients who come from all over the world for treatment. TrueBeam opens the door to some exciting cutting-edge treatment capabilities that will be made available to patients in coming years."
The order for the systems was booked in March during the second quarter of the company's fiscal year 2016.
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging. The company is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiation. The company provides comprehensive solutions for radiotherapy, radiosurgery, proton therapy and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is also a premier supplier of X-ray imaging components, including tubes, digital detectors, cables and connectors as well as image processing software and workstations for use in medical and industrial settings, as well as for security and non-destructive testing. Varian Medical Systems employs approximately 7,500 people who are located at manufacturing sites in North America, Europe, and China and sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.
Forward Looking Statement
Except for historical information, this news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning industry outlook, including growth drivers; the company's future orders, revenues or other financial performance; the ability of the company's technology and products to treat cancer; customer delivery schedules; and any statements using the terms "scheduled," "will," "improve," "opens the door," "coming," or similar statements are forward-looking statements that involve risks and uncertainties that could cause the company's actual results to differ materially from those anticipated. Such risks and uncertainties include the demand for the company's products; the company's ability to develop, commercialize, and deploy new and existing products; the impact of competitive products and pricing; the effect of global economic conditions; the company's ability to meet legal and regulatory requirements; changes in the legal or regulatory environment; and the other risks listed from time to time in the company's filings with the Securities and Exchange Commission, which by this reference are incorporated herein. The company assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.
Press Contact
Mark Plungy
Varian Medical Systems
+1 (650) 424-5630
mark.plungy@varian.com
SOURCE Varian Medical Systems